fda_483 · inspection_citation · high

SCA Pharmaceuticals LLC -- FDA 483: 2 observations (2026-03-13)

Event date
2026-03-13 00:00:00Z
Observed
2026-07-12 22:30:45Z
Source ID
3013736415-2026-03-13-192262
Payload hash
bc437f7836bfe81d43ecebff

Summary

Observation 1: Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are not established and followed. Specifically, Procedures designed to prevent mic...

Informational only. Not legal, financial, or medical advice.